Rene Baudrand Selected Research

Cortisone

1/2020	Classic and Nonclassic Apparent Mineralocorticoid Excess Syndrome.
1/2019	Clinical, Biochemical, and Genetic Characteristics of "Nonclassic" Apparent Mineralocorticoid Excess Syndrome.
1/2018	Serum Cortisol and Cortisone as Potential Biomarkers of Partial 11β-Hydroxysteroid Dehydrogenase Type 2 Deficiency.
1/2016	Cortisol/cortisone ratio and matrix metalloproteinase-9 activity are associated with pediatric primary hypertension.
1/2016	Citosine-Adenine-Repeat Microsatellite of 11β-hydroxysteroid dehydrogenase 2 Gene in Hypertensive Children.
4/2013	Age-related changes in 11β-hydroxysteroid dehydrogenase type 2 activity in normotensive subjects.
5/2012	11β-hydroxysteroid dehydrogenase type 2 polymorphisms and activity in a Chilean essential hypertensive and normotensive cohort.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rene Baudrand Research Topics

Disease

20	Hypertension (High Blood Pressure) 10/2021 - 12/2011
7	Hyperaldosteronism (Conn Syndrome) 01/2019 - 01/2016
7	Obesity 01/2019 - 10/2010
6	Insulin Resistance 03/2016 - 10/2010
5	Cardiovascular Diseases (Cardiovascular Disease) 11/2018 - 01/2014
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019 - 12/2011
4	Inflammation (Inflammations) 11/2018 - 03/2014
3	Non-alcoholic Fatty Liver Disease 09/2021 - 10/2010
3	Essential Hypertension 01/2020 - 02/2010
3	Dyslipidemias (Dyslipidemia) 03/2016 - 12/2011
3	Cushing Syndrome 06/2015 - 12/2011
2	Hypokalemia 01/2019 - 12/2018
2	Stroke (Strokes) 11/2018 - 10/2016
2	Apparent Mineralocorticoid Excess Syndrome 01/2018 - 01/2016
2	Liver Cirrhosis (Hepatic Cirrhosis) 09/2015 - 10/2010
2	Fibrosis (Cirrhosis) 09/2015 - 10/2010
2	Type 2 Diabetes Mellitus (MODY) 03/2014 - 10/2010
1	Occupational Stress 01/2022
1	Hypertensive Crisis 10/2021
1	Hypotension (Low Blood Pressure) 01/2020
1	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 01/2020
1	Albuminuria 01/2020
1	Kidney Diseases (Kidney Disease) 12/2018
1	Alkalosis 12/2018
1	Atherosclerosis 11/2017
1	Vascular Diseases (Vascular Disease) 01/2017
1	Noncommunicable Diseases 10/2016
1	Hyperglycemia 01/2016
1	Morbid Obesity 01/2016
1	Hypertriglyceridemia 01/2016
1	Alcoholic Fatty Liver 09/2015
1	Abdominal Obesity 12/2011
1	Hypoadiponectinemia 12/2011

Drug/Important Bio-Agent (IBA)

15	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 09/2021 - 04/2013
15	AldosteroneIBA 09/2021 - 01/2014
10	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022 - 12/2011
10	ReninIBA 01/2020 - 01/2016
8	SodiumIBA 09/2021 - 01/2014
7	Cortisone FDA Link 01/2020 - 05/2012
7	Oxidoreductases (Dehydrogenase)IBA 01/2016 - 02/2010
4	EnzymesIBA 01/2016 - 03/2012
3	MineralocorticoidsIBA 01/2020 - 06/2015
3	methylamphotericin B (AME)IBA 01/2020 - 01/2018
3	PotassiumIBA 01/2020 - 01/2017
2	Dietary SodiumIBA 09/2021 - 11/2016
2	SaltsIBA 01/2020 - 01/2014
2	Angiotensin IIIBA 12/2018 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 11/2018 - 01/2016
2	LeptinIBA 03/2016 - 10/2010
2	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 10/2010
2	C-Reactive ProteinIBA 01/2016 - 03/2014
2	Interleukin-6 (Interleukin 6)IBA 01/2016 - 03/2014
2	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2016 - 09/2015
2	AdiponectinIBA 01/2016 - 10/2010
1	Adrenergic Agents (Adrenergic Drugs)IBA 10/2021
1	CatecholaminesIBA 10/2021
1	Antihypertensive Agents (Antihypertensives)IBA 11/2017
1	Hormones (Hormone)IBA 03/2016
1	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 01/2016
1	NADPH Oxidase 4IBA 01/2016
1	Aldehyde Reductase (Aldose Reductase)IBA 01/2016
1	CholesterolIBA 01/2016
1	HDL LipoproteinsIBA 01/2016
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	Plasminogen InactivatorsIBA 01/2016
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2016
1	ResistinIBA 01/2016
1	Caveolin 1IBA 12/2015
1	Genetic Markers (Genetic Marker)IBA 12/2015
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2015
1	Eplerenone (Inspra)FDA LinkGeneric 09/2015
1	Collagen Type III (Type III Collagen)IBA 09/2015
1	Transaminases (Aminotransferases)IBA 09/2015
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 06/2015
1	Protein Isoforms (Isoforms)IBA 03/2014
1	Interleukin-8 (Interleukin 8)IBA 03/2014
1	Malondialdehyde (Propanedial)IBA 03/2014
1	GTP Phosphohydrolases (GTPases)IBA 03/2014
1	Metalloproteases (Metalloproteinases)IBA 03/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2014
1	Plasminogen Activator Inhibitor 1IBA 03/2014
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2012
1	GlucocorticoidsIBA 12/2011
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 10/2010
1	Alanine Transaminase (SGPT)IBA 10/2010

Therapy/Procedure

1	Therapeutics 03/2016